| Year |
Citation |
Score |
| 2020 |
Adnani MT, Galli S, Hong SH, Tilan JU, Kitlinska J. Abstract 6159: Blocking neuropeptide Y Y5 receptor prevents hypoxia-induced Ewing sarcoma metastasis Tumor Biology. DOI: 10.1158/1538-7445.Am2020-6159 |
0.377 |
|
| 2019 |
Krawczyk E, Hong SH, Galli S, Trinh E, Wietlisbach L, Misiukiewicz SF, Tilan JU, Chen YS, Schlegel R, Kitlinska J. Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 31409888 DOI: 10.1038/S41374-019-0297-7 |
0.346 |
|
| 2019 |
Zhu S, Mahajan A, Hong S, Galli S, Lu C, Chen Y, Misiukiewicz S, Chung S, Tilan J, Kitlinska JB. Abstract 3664: Hypoxia-induced phenotypic and metabolic changes in Ewing sarcoma cells trigger bone metastasis Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3664 |
0.314 |
|
| 2018 |
Mahajan A, Hong S, Galli S, Lu C, Zhu S, Tilan J, Cavalli L, Kitlinska J. Abstract PR15: Hypoxia, polyploidy, neuropeptide Y, and Ewing sarcoma bone metastases: Is there a link? Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-Pr15 |
0.409 |
|
| 2018 |
Galli S, Hong S, Tilan JU, Adnani M, Zhu S, Fallah Y, Lee Y, Rodriguez O, Albanese C, Izycka-Swieszewska E, Kitlinska J. Abstract B13: Perineural invasion in Ewing sarcoma—a novel mechanism and new therapeutic opportunities Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B13 |
0.427 |
|
| 2017 |
Hong SH, Wietlisbach L, Galli S, Mahajan A, Zhu S, Tilan J, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 1940: Prenatal stress increases malignancy of neuroblastoma tumors in TH-MYCN animal model Cancer Research. 77: 1940-1940. DOI: 10.1158/1538-7445.Am2017-1940 |
0.384 |
|
| 2016 |
Hong SH, Tilan JU, Galli S, Acree R, Connors K, Mahajan A, Wietlisbach L, Polk T, Izycka-Swieszewska E, Lee YC, Cavalli LR, Rodriguez OC, Albanese C, Kitlinska JB. In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. Journal of Visualized Experiments : Jove. PMID 28060251 DOI: 10.3791/54532 |
0.36 |
|
| 2016 |
Galli S, Naranjo A, Van Ryn C, Tilan JU, Trinh E, Yang C, Tsuei J, Hong SH, Wang H, Izycka-Swieszewska E, Lee YC, Rodriguez OC, Albanese C, Kitlinska J. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. The American Journal of Pathology. PMID 27743558 DOI: 10.1016/J.Ajpath.2016.07.019 |
0.424 |
|
| 2016 |
Paiva SP, Veloso CA, Campos FF, Carneiro MM, Tilan JU, Wang H, Umans JG, Zukowska Z, Kitlinska J. Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease. Neuropeptides. 55: 127-35. PMID 26431933 DOI: 10.1016/J.Npep.2015.09.006 |
0.646 |
|
| 2016 |
Tilan JU, Hong S, Galli S, Acree R, Connors K, Horton M, Mahajan A, Wietlisbach L, Lee Y, Rodriguez O, Albanese C, Kitlinska J. Abstract 2478: Tumor hypoxia promotes Ewing sarcoma metastases in a mouse xenograft model Cancer Research. 76: 2478-2478. DOI: 10.1158/1538-7445.Am2016-2478 |
0.388 |
|
| 2016 |
Mahajan A, Hong S, Tilan JU, Galli S, Lu C, Rodgers J, Duttargi A, Acree R, Cavalli LR, Kitlinska JB. Abstract 2443: Ewing sarcoma progression associates with increasing chromosomal instability: A role for neuropeptide Y and its Y5 receptor Cancer Research. 76: 2443-2443. DOI: 10.1158/1538-7445.Am2016-2443 |
0.411 |
|
| 2016 |
Tilan JU, Galli S, Hong S, Izycka-Swieszewska E, Mahajan A, Cavalli L, Acree R, Connors K, Lu C, Kitlinska J. Neuropeptide Y (NPY) in tumor metastasis and bone invasion: Hypoxia as a trigger Neuropeptides. 55: 8. DOI: 10.1016/J.Npep.2015.11.020 |
0.352 |
|
| 2015 |
Tilan J, Kitlinska J. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology. Neuropeptides. 55: 55-66. PMID 26549645 DOI: 10.1016/J.Npep.2015.10.005 |
0.416 |
|
| 2015 |
Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases. Oncotarget. 6: 7151-65. PMID 25714031 DOI: 10.18632/Oncotarget.3345 |
0.353 |
|
| 2015 |
Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Cancer. 121: 697-707. PMID 25387699 DOI: 10.1002/Cncr.29090 |
0.348 |
|
| 2015 |
Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, Tilan JU, Talisman N, Izycka-Swieszewska E, Tsuei J, Yang C, Martin S, Horton M, Christian D, Everhart L, et al. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance. Oncogene. 34: 3131-43. PMID 25132261 DOI: 10.1038/Onc.2014.253 |
0.425 |
|
| 2015 |
Hong S, Christian D, Trinh E, Galli S, Horton M, Lee Y, Albanese C, Rodriguez O, Tilan JU, Kitlinska J. Abstract 3291: Prenatal stress increases neuroblastoma tumorigenesis in TH-MYCN mice model Cancer Research. 75: 3291-3291. DOI: 10.1158/1538-7445.Am2015-3291 |
0.378 |
|
| 2015 |
Galli S, Tilan J, Naranjo A, Ryn CV, Yang C, Tsuei J, Trinh E, Kitlinska JB. Abstract 1628: Neuropeptide Y (NPY) and its receptor expression in neuroblastoma patients - associations with disease prognosis and patients’ survival Cancer Research. 75: 1628-1628. DOI: 10.1158/1538-7445.Am2015-1628 |
0.389 |
|
| 2014 |
Hong S, Galli S, Tilan J, Christian D, Horton M, Rodriguez O, Albanese C, Kitlinska J. Abstract A52: In vivo model of Ewings sarcoma metastases Cancer Research. 74. DOI: 10.1158/1538-7445.Pedcan-A52 |
0.342 |
|
| 2014 |
Trinh E, Czarnecka M, Hong S, Lu C, Martin S, Galli S, Izycka-Swieszewska E, Kuan-Celarier A, Christian D, Horton M, Tilan JU, Kitlinska JB. Abstract 3105: Neuropeptide Y Y5 receptor in neuroblastoma chemoresistance Cancer Research. 74: 3105-3105. DOI: 10.1158/1538-7445.Am2014-3105 |
0.438 |
|
| 2013 |
Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, et al. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects. Oncotarget. 4: 2487-501. PMID 24318733 DOI: 10.18632/Oncotarget.1604 |
0.41 |
|
| 2013 |
Tilan JU, Everhart LM, Abe K, Kuo-Bonde L, Chalothorn D, Kitlinska J, Burnett MS, Epstein SE, Faber JE, Zukowska Z. Platelet neuropeptide Y is critical for ischemic revascularization in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2244-55. PMID 23457218 DOI: 10.1096/Fj.12-213546 |
0.646 |
|
| 2013 |
Najafi AH, Aghili N, Tilan JU, Andrews JA, Peng X, Lassance-Soares RM, Sood S, Alderman LO, Abe K, Li L, Kolodgie FD, Virmani R, Zukowska Z, Epstein SE, Burnett MS. A new murine model of stress-induced complex atherosclerotic lesions. Disease Models & Mechanisms. 6: 323-31. PMID 23324329 DOI: 10.1242/Dmm.009977 |
0.605 |
|
| 2012 |
Eshkevari L, Egan R, Phillips D, Tilan J, Carney E, Azzam N, Amri H, Mulroney SE. Acupuncture at ST36 prevents chronic stress-induced increases in neuropeptide Y in rat. Experimental Biology and Medicine (Maywood, N.J.). 237: 18-23. PMID 22156045 DOI: 10.1258/Ebm.2011.011224 |
0.347 |
|
| 2012 |
Tilan JU, Izycka-Swieszewska E, Earnest JP, Galli S, Shabbir A, Lu C, Czarnecka M, Rodriguez O, Albanese C, Kitlinska J. Abstract LB-186: Differential effects of stress on tumor initiation and progression - role of neuropeptide Y Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-186 |
0.434 |
|
| 2012 |
Tilan JU, Lu C, Earnest JP, Everhart LM, Shabir A, O'Neill A, Wang S, Czarnecka M, Toretsky JA, Kitlinska J. Abstract 3950: Differential functions of neuropeptide Y in Ewing's sarcoma - hypoxia as a switch Cancer Research. 72: 3950-3950. DOI: 10.1158/1538-7445.Am2012-3950 |
0.44 |
|
| 2011 |
Tassi E, McDonnell K, Gibby KA, Tilan JU, Kim SE, Kodack DP, Schmidt MO, Sharif GM, Wilcox CS, Welch WJ, Gallicano GI, Johnson MD, Riegel AT, Wellstein A. Impact of fibroblast growth factor-binding protein-1 expression on angiogenesis and wound healing. The American Journal of Pathology. 179: 2220-32. PMID 21945411 DOI: 10.1016/J.Ajpath.2011.07.043 |
0.32 |
|
| 2011 |
Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J. Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. The Journal of Biological Chemistry. 286: 27494-505. PMID 21680731 DOI: 10.1074/Jbc.M111.224089 |
0.406 |
|
| 2011 |
Tilan JU, Mtaweh H, Everhart LM, Long J, Barkauskas DA, Krailo M, Jeha D, Toretsky J, Kitlinska J. Abstract 4352: Systemic levels of neuropeptide Y are elevated in Ewing's sarcoma patients Cancer Research. 71: 4352-4352. DOI: 10.1158/1538-7445.Am2011-4352 |
0.38 |
|
| 2011 |
Lu C, Everhart L, Tilan JU, Czarnecka M, Hanafy J, Jeha D, Toretsky JA, Kitlinska JB. Abstract 187: Dipeptidyl peptidases abolish growth inhibitory effect of neuropeptide Y in Ewing's sarcoma family of tumors Cancer Research. 71: 187-187. DOI: 10.1158/1538-7445.Am2011-187 |
0.442 |
|
| 2011 |
Abe K, Saadat S, Fennessy J, Dandamudi S, Kitlinska J, Tilan J, Lu C, Hellerstein M, Zukowska Z. 569 SYMPATHETIC OUTFLOW TO BONE MARROW MEGAKARYOCYTES STIMULATES NEOINTIMA FORMATION VIA PLATELET-DERIVED NEUROPEPTIDE Y Atherosclerosis Supplements. 12: 120-121. DOI: 10.1016/S1567-5688(11)70570-0 |
0.61 |
|
| 2010 |
Lu C, Everhart L, Tilan J, Kuo L, Sun CCJ, Munivenkatappa RB, Jönsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J. Neuropeptide y and its Y2 receptor: Potential targets in neuroblastoma therapy Oncogene. 29: 5630-5642. PMID 20676138 DOI: 10.1038/Onc.2010.301 |
0.687 |
|
| 2010 |
Tilan J, Kitlinska J. Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression. Journal of Oncology. 2010: 539706. PMID 20508839 DOI: 10.1155/2010/539706 |
0.424 |
|
| 2008 |
Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Annals of the New York Academy of Sciences. 1148: 232-7. PMID 19120115 DOI: 10.1196/Annals.1410.035 |
0.665 |
|
| 2007 |
Abe K, Tilan JU, Zukowska Z. NPY and NPY receptors in vascular remodeling. Current Topics in Medicinal Chemistry. 7: 1704-9. PMID 17979779 DOI: 10.2174/156802607782340948 |
0.657 |
|
| 2007 |
Callanan EY, Lee EW, Tilan JU, Winaver J, Haramati A, Mulroney SE, Zukowska Z. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. American Journal of Physiology. Renal Physiology. 293: F1811-7. PMID 17804485 DOI: 10.1152/Ajprenal.00191.2007 |
0.615 |
|
| 2007 |
Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nature Medicine. 13: 803-11. PMID 17603492 DOI: 10.1038/Nm1611 |
0.661 |
|
| 2007 |
Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, Herzog H, Zukowska Z. Erratum: Corrigenda: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome Nature Medicine. 13: 1120-1120. DOI: 10.1038/Nm0907-1120 |
0.638 |
|
| 2006 |
Kitlinska J, Kuo L, Abe K, Pons J, Yu M, Li L, Tilan J, Toretsky J, Zukowska Z. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth Advances in Experimental Medicine and Biology.. 575: 223-229. PMID 16700526 DOI: 10.1007/0-387-32824-6_24 |
0.623 |
|
| 2005 |
Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Research. 65: 1719-28. PMID 15753367 DOI: 10.1158/0008-5472.Can-04-2192 |
0.683 |
|
| Show low-probability matches. |